News_en

Taipei City | Date: January 2, 2025 YC Biotech Co., Ltd. has built a strong collaborative relationship with Shuang Ho Hospital, which is part of the Taipei Medical University Healthcare System. In 2025, this partnership will advance further with research focused on stem cell cultivation and exosome technology development. The study is set to begin […]

January 1, 2025, Taipei — YC Biotech Co., Ltd. (hereinafter referred to as “YC Biotech”) and Taipei Medical University (hereinafter referred to as “TMU”) officially announced today that they will jointly execute the “Global Market Analysis of Biomedical Implants” industry-academia collaboration project from January 1, 2025, to December 31, 2025. This project aims to integrate

New Taipei City | Date: November 5, 2024 YC Biotech CO., LTD. is proud to announce its expansion into Taipei Medical University’s Shuang Ho Biotech Park, with plans to develop state-of-the-art laboratories dedicated to driving innovation in precision medicine and regenerative medicine. This move signifies a significant step forward in the collaboration between YC Biotech,

Taipei | October 17, 2024 YC Biotech CO., LTD. announced recently that it has signed a Memorandum of Understanding (MOU) with YD Biopharma Co., Ltd. to jointly advance the development and clinical trials of LENSMATE contact lenses and EXOLENS corneal tear-related products, derived from human limbal stem cell (LSC) technology. Under the terms of the

Taipei City | Date: September, 2024 YC Biotech CO., LTD. is excited to announce its official collaboration with Sentronic International Corp. to launch the clinical trial for the G-BeBite® Dental Implant System. This groundbreaking project, commissioned by Sentronic International Corp., designates YC Biotech as the contracted research organization (CRO), responsible for designing, planning, and executing the

Location: Manama, Bahrain | Date: June 18, 2024 YC Biotech CO., LTD. was honored to participate in a prestigious medical conference organized by the Economic Development Board (EDB Bahrain). Representing Taiwan’s biotechnology industry, YC Biotech showcased its groundbreaking advancements in stem cell exosome technology and cancer methylation detection to key officials and medical experts in

YC Biotech and Friendly Taipei Community Health Care Group successfully held a signing event at Brown Cafe, announcing their partnership to promote EG BioMed’s DNA Methylation Cancer Biomarker Test. This collaboration marks a significant advancement in breast cancer detection methods, with the technology standing out for its simplicity, speed, and accuracy, offering a more comfortable

Taipei City | Date: November 7, 2023 YC Biotech Co., Ltd. recently conducted animal trials for the G-BeBite dental implant system, with promising results from performance studies on the mandibular bone of Lanyu miniature pigs. Early data indicates that this implant system demonstrates exceptional osseointegration and favorable safety in local biocompatibility tests, further reinforcing its

YC Biotech Corporation and Xindian-Wenshan Community Health Care Group have officially joined forces to introduce EG BioMed’s DNA methylation cancer indicator testing technology to the Taiwan market. The partnership was celebrated on the 17th with a signing ceremony banquet at Su-Hang Restaurant, where both parties reaffirmed their commitment to making innovative cancer detection more widely